Dianthus Therapeutics, Inc. (DNTH)
88.42
-3.39
(-3.69%)
USD |
NASDAQ |
Nov 16, 14:07
Dianthus Therapeutics Price to Book Value : 4.010 for Nov. 16, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 4.163 |
| November 12, 2026 | 4.194 |
| November 11, 2026 | 4.050 |
| November 10, 2026 | 4.027 |
| November 09, 2026 | 4.081 |
| November 06, 2026 | 3.901 |
| November 05, 2026 | 3.764 |
| November 04, 2026 | 3.891 |
| November 03, 2026 | 3.750 |
| November 02, 2026 | 3.730 |
| October 30, 2026 | 3.736 |
| October 29, 2026 | 3.750 |
| October 28, 2026 | 3.732 |
| October 27, 2026 | 3.606 |
| October 26, 2026 | 3.597 |
| October 23, 2026 | 3.482 |
| October 22, 2026 | 3.561 |
| October 21, 2026 | 3.542 |
| October 20, 2026 | 3.571 |
| October 19, 2026 | 3.380 |
| October 16, 2026 | 3.269 |
| October 15, 2026 | 3.380 |
| October 14, 2026 | 3.390 |
| October 13, 2026 | 3.518 |
| October 12, 2026 | 3.699 |
| Date | Value |
|---|---|
| October 09, 2026 | 3.735 |
| October 08, 2026 | 3.738 |
| October 07, 2026 | 3.849 |
| October 06, 2026 | 3.873 |
| October 05, 2026 | 3.992 |
| October 02, 2026 | 4.000 |
| October 01, 2026 | 4.005 |
| September 30, 2026 | 3.993 |
| September 29, 2026 | 4.075 |
| September 28, 2026 | 4.106 |
| September 25, 2026 | 4.140 |
| September 24, 2026 | 4.241 |
| September 23, 2026 | 4.369 |
| September 22, 2026 | 4.598 |
| September 21, 2026 | 4.510 |
| September 18, 2026 | 4.526 |
| September 17, 2026 | 4.728 |
| September 16, 2026 | 4.792 |
| September 15, 2026 | 4.898 |
| September 14, 2026 | 5.035 |
| September 11, 2026 | 4.965 |
| September 10, 2026 | 4.829 |
| September 09, 2026 | 5.005 |
| September 08, 2026 | 5.102 |
| September 04, 2026 | 5.054 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Xencor, Inc. | 4.753 |
| ACADIA Pharmaceuticals, Inc. | 2.387 |
| Alnylam Pharmaceuticals, Inc. | 5.936 |
| Anika Therapeutics, Inc. | 1.266 |
| Savara, Inc. | 8.442 |
Price to Book Value Related Metrics
| PS Ratio | 1678.41 |
| PEG Ratio | -1.546 |
| Price | 88.42 |
| Earnings Yield | -4.52% |
| Market Cap | 4.978B |
| PEGY Ratio | -1.546 |